By : JD staff
Jordan Daily – Dar Al Dawa Development and Investment Company, a leading pharmaceutical manufacturer in Jordan, reported a 19% increase in profit for the first quarter of 2025, driven by robust sales growth, according to its financial statement ,seen by Jordan Daily.
The public shareholding company posted a profit of JD 586,277 for the three months ended March 31, 2025, up from JD 494,354 in the same period last year. Revenue from contracts with customers rose 10% to JD18.2 million, fueled by strong demand in the Levant, Iraq, and African markets. The company’s gross profit margin improved to 43.9% from 43%, reflecting efficient cost management despite a 9% rise in cost of sales to JD10.2 million.
Dar Al Dawa’s diversified portfolio, including medicines and baby food, contributed to the revenue growth. Sales in the Levant and Iraq surged 68% to JD11.8 million , while Africa accounted for JD 4.2 million . The company’s focus on expanding its regional footprint, particularly through its subsidiaries in Algeria, Tunisia, and Romania, bolstered its performance.
The company’s total assets remained stable at JD124.3 million , with cash and bank balances increasing to JD 16.4 million from JD15.6 million at the end of 2024. However, net cash flows from operating activities were negative at JD 3.2 million , primarily due to a JD 5 million reduction in trade payables. Financing activities generated JD 3.2 million , supported by new loan proceeds of JD 4.9 million.
In a strategic move, Dar Al Dawa’s General Assembly approved a JD15 million capital increase on April 24, 2025, raising the authorized paid-in capital to JD 50 million through a private subscription for shareholders. This move aims to strengthen the company’s financial position and support its expansion plans, including investments in manufacturing and regional markets.
Dar Al Dawa, established in 1975, operates across Jordan, Algeria, Tunisia, Romania, and Saudi Arabia, with a focus on pharmaceuticals and related products. The company’s shares are listed on the Amman Stock Exchange.
